Consequently, results have been returned for TTR variants associated with hereditary transthyretin amyloidosis (hATTR), a condition predominantly affecting African ancestry populations in the USA [15], with newly approved therapeutics to improve health outcomes [16]. The gene discussed is TTR; the disease is Familial transthyretin-related amyloidosis.